Position in GSK
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,213,103
+$32,479 QoQ
Shares Held
23,142
+8.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#324
of 1,033 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DEARBORN PARTNERS LLC holds $75,110,921 across 10 Drug Manufacturers - General names. GSK ranks #7 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
114,591 | $28,835,679 | |
| 2 | JNJ |
Johnson & Johnson
|
79,895 | $20,290,932 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
67,003 | $8,465,159 | |
| 4 | LLY |
ELI LILLY & Co
|
4,621 | $5,542,566 | |
| 5 | NVS |
Novartis AG
|
32,039 | $5,021,152 | |
| 6 | MRK |
Merck & Co., Inc.
|
28,921 | $3,716,348 | |
| 7 | GSK |
GSK plc
This page
|
23,142 | $1,213,103 | |
| 8 | PFE |
Pfizer Inc
|
40,635 | $978,490 |
All Filings in GSK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,213,103 | 23,142 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,180,624 | 21,392 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,049,063 | 21,392 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $923,278 | 21,392 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $821,452 | 21,392 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $712,506 | 18,392 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $507,029 | 14,992 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $510,672 | 12,492 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $442,442 | 11,492 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $556,967 | 12,992 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $396,245 | 10,692 | Shares | Sole | 2024-01-26 | |
| 2022-06-30 | $297,365 | 6,965 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $275,994 | 6,460 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $279,978 | 6,473 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $242,397 | 6,468 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $251,751 | 6,446 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $225,430 | 6,440 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $232,261 | 6,435 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $254,914 | 6,905 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $276,087 | 6,901 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $256,272 | 6,896 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||